Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to -$38839.7.

  • Addex Therapeutics' Exchange Rate Effect rose 10000.0% to -$38839.7 in Q2 2025 from the same period last year, while for Jun 2025 it was $836.4 million, marking a year-over-year decrease of 9951.94%. This contributed to the annual value of $113308.7 for FY2024, which is 12850.95% up from last year.
  • According to the latest figures from Q2 2025, Addex Therapeutics' Exchange Rate Effect is -$38839.7, which was up 10000.0% from $144.59 recorded in Q1 2025.
  • Addex Therapeutics' Exchange Rate Effect's 5-year high stood at $170.1 billion during Q4 2023, with a 5-year trough of -$108.4 billion in Q2 2024.
  • Over the past 4 years, Addex Therapeutics' median Exchange Rate Effect value was -$151.27 (recorded in 2022), while the average stood at $12.5 billion.
  • Data for Addex Therapeutics' Exchange Rate Effect shows a peak YoY increase of 12819598435834.77% (in 2024) and a maximum YoY decrease of 995184853444.76% (in 2024) over the last 5 years.
  • Addex Therapeutics' Exchange Rate Effect (Quarter) stood at -$233588.1 in 2022, then skyrocketed by 72829481.37% to $170.1 billion in 2023, then crashed by 144.25% to -$75.3 billion in 2024, then surged by 100.0% to -$38839.7 in 2025.
  • Its last three reported values are -$38839.7 in Q2 2025, $144.59 for Q1 2025, and -$75.3 billion during Q4 2024.